Navigation Links
Halozyme Therapeutics Announces Positive Findings With Pegylated Enzyme in Prostate Cancer Models
Date:7/22/2008

e span by 225% while docetaxel alone increased life span by 59% relative to control. Furthermore, the survival benefit produced by the combination treatment was significantly better than docetaxel alone (p=0.003).

Xenograft Du145luc results

-- Tumor volume growth unaffected by combination treatment, as expected. Human Du145luc prostate tumor cells do not produce hyaluronan, and no change in interstitial fluid pressure was observed following PEGPH20 treatment. Therefore, treatment with an HA-reducing treatment regimen would not be expected to provide a therapeutic benefit. Results demonstrated no meaningful difference in tumor volume between the docetaxel alone and PEGPH20 plus docetaxel treatment groups. In addition, unlike the HA-producing PC3 tumors, tumor growth curves in the control and the PEGPH20 groups were virtually superimposable. These findings support the proposed mechanism of action that only HA-producing tumors would be most susceptible to PEGPH20.

PC3-M-luc bone metastases results

-- Survival benefit demonstrated. Two different combination dosage regimens of PEGPH20 plus docetaxel demonstrated improved survival compared to the control group. For this model, tumor cells are injected directly into the left ventricle and migrate to bone tissue.

Hyaluronan is a dominant constituent of the extracellular matrix in subsets of many solid tumor types, including prostate, breast, ovarian, pancreatic, and gastric, where it may increase the resistance to chemotherapeutic agents. Previous studies presented by Halozyme (Thompson et al. Proceedings AACR Annual Meeting, Volume 49, April 2008) demonstrated significant reductions of HA around the tumor, IFP, and tumor water content after intravenous administration of PEGPH20. Elevated tumor IFP is believed to limit the response to cytotoxic treatment regimens in many solid tumors. Removal of peritumoral HA and the lowering of IFP may potentially lead to improved responses to chemothera
'/>"/>

SOURCE Halozyme Therapeutics, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Halozyme Therapeutics Announces That Chemophase Meets Primary Endpoint in Phase I/IIa Clinical Trial
2. Halozyme Therapeutics Announces Phase I Clinical Trial Results Demonstrating that the Combination of Recombinant Human Hyaluronidase (rHuPH20) With Humulin R(R) and with Humalog(R) Yields Faster, More Physiologic Insulin Kinetics and Better Predictability
3. Halozyme Therapeutics Presents Findings on Combinations of rHuPH20 Enzyme With Bisphosphonates at the American Association for Cancer Research Conference
4. Halozyme Therapeutics Presents Pre-Clinical Studies of Systemic Delivery of Pegylated rHuPH20 Enyzme in Prostate Cancer Models at American Association for Cancer Research Conference
5. Halozyme Therapeutics Announces Peer-Reviewed Publications of the INFUSE-LR Clinical Trial Results and Clinical Practice Experience With Hylenex
6. Halozyme Therapeutics Completes Enrollment in Chemophase Phase I/IIa Clinical Trial for Superficial Bladder Cancer
7. Paper in Molecular Cancer Therapeutics Reports that a Novel Combination of Alfacells ONCONASE(R) and Rosiglitazone Induces a Synergistic Apoptotic Effect in Several Cancer Cell Lines
8. Velcura Therapeutics, Inc. Adds William Brinkerhoff to its Board of Directors
9. PTC Therapeutics Announces $25 Million Award From Cystic Fibrosis Foundation Therapeutics for Development of PTC124
10. Echo Therapeutics Announces Publication of Positive Clinical Data for its Symphony Transdermal Continuous Glucose Monitoring System in Journal of Diabetes Science and Technology
11. Nile Therapeutics Announces Dosing in Phase IIa Study of CD-NP in Heart Failure Patients
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/3/2015)... N.J. , Aug. 3, 2015 Ortho ... has been named Chief Corporate Brand and Communications ... firm,s executive leadership team, Bouryal will lead the company,s ... builds on its transition to an independent company by ... report to Chairman and Chief Executive Officer Dr. ...
(Date:8/3/2015)... , August 3, 2015 ... Persistence Market Research "Global Market Study on Physiotherapy ... Witness Highest Growth by 2022", the global physiotherapy equipment ... the end of 2015 and is expected to ... to 2022, to account for US$23.7 Bn by 2022. ...
(Date:8/3/2015)... NEWS, Va. , Aug. 3, 2015 /PRNewswire/ ... be joining Orthopaedic & Spine Center ... them to manage their chronic pain through psychological ... Robinson is a Fellowship-trained, certified medical psychologist ... pain medicine. His vast experience ranges from assessment ...
Breaking Medicine Technology:Ortho Clinical Diagnostics Appoints Kristie Bouryal Chief Corporate Brand and Communications Officer 2Global Physiotherapy Equipment Market Will Reach US$ 23.7 Billion by 2022: Persistence Market Research 2Global Physiotherapy Equipment Market Will Reach US$ 23.7 Billion by 2022: Persistence Market Research 3Global Physiotherapy Equipment Market Will Reach US$ 23.7 Billion by 2022: Persistence Market Research 4Orthopaedic & Spine Center Introduces New Pain Psychologist 2
... (NYSE: CBM ) reports fourth quarter and full year ... Highlights Reported sales increased by 8.2%, ... to fourth quarter 2009. Adjusted EBITDA was $14.5 million in ... million of EBITDA in the fourth quarter of 2009. Debt, ...
... the Obama administration embarks on improving the efficiency of ... for Medicare & Medicaid Services, (CMS) supervision of the ... hard pressed to find a government operation more outdated, ... In fact, recent audits by the government,s own contractors ...
Cached Medicine Technology:Cambrex Reports Fourth Quarter and Full Year 2010 Results 2Cambrex Reports Fourth Quarter and Full Year 2010 Results 3Cambrex Reports Fourth Quarter and Full Year 2010 Results 4Cambrex Reports Fourth Quarter and Full Year 2010 Results 5Cambrex Reports Fourth Quarter and Full Year 2010 Results 6Cambrex Reports Fourth Quarter and Full Year 2010 Results 7Cambrex Reports Fourth Quarter and Full Year 2010 Results 8Cambrex Reports Fourth Quarter and Full Year 2010 Results 9Mobility Matters: Frustrated Mobility Providers Ask White House to Address Gross Mismanagement of Mobility Benefit 2Mobility Matters: Frustrated Mobility Providers Ask White House to Address Gross Mismanagement of Mobility Benefit 3Mobility Matters: Frustrated Mobility Providers Ask White House to Address Gross Mismanagement of Mobility Benefit 4Mobility Matters: Frustrated Mobility Providers Ask White House to Address Gross Mismanagement of Mobility Benefit 5
(Date:8/4/2015)... ... 2015 , ... Healthcare IT News (HITN), the ... healthcare and technology markets, today announced significant spikes in website traffic and social ... Record (EHR) decision. The DOD related numbers solidify HITN’s status as the leading ...
(Date:8/3/2015)... ... August 04, 2015 , ... ... CE courses for rehabilitation professionals, HomeCEUConnection.com today announced extra savings on Florida ... now take advantage of big savings on Physical Therapy Flex packages ...
(Date:8/3/2015)... ... August 03, 2015 , ... sweetFrog Enterprises, LLC. is pleased to ... 20th sweetFrog store operating in the Lone Star State. The premium frozen yogurt chain ... 2014. , The store, located at 2916 US-75, Sherman, TX 38652, will have grand ...
(Date:8/3/2015)... ... August 03, 2015 , ... ... Constitution, the new Lifetime reality series, “Atlanta Plastic” is getting attention for moving ... plastic surgery, with its predominantly African-American cast of doctors and patients. Beverly Hills ...
(Date:8/3/2015)... ... 03, 2015 , ... BESLER Consulting today announced the firm ... The MarketingProfs Bright Bulb B2B Awards celebrate the best marketing, communications, and creative ... of their Readmissions Analytics product was selected as one of four finalists in ...
Breaking Medicine News(10 mins):Health News:Coverage of DOD’s EHR Decision Reinforces Healthcare IT News’ Leadership 2Health News:Elite Online CE Provider Offers Discounted Flexible Packages to Meet Florida Physical Therapy Continuing Education Requirements 2Health News:sweetFrog Reopens Texas Store Today 2Health News:Article on Lifetime’s New “Atlanta Plastic” Reality Series Underlines the Diversity of Today’s Plastic Surgery Patients, Says Plastic Surgeon Dr. J 2Health News:Article on Lifetime’s New “Atlanta Plastic” Reality Series Underlines the Diversity of Today’s Plastic Surgery Patients, Says Plastic Surgeon Dr. J 3
... Logical Policy in Regard to Boosting LTC Jobs, Protecting ... A national coalition of front line caregivers today ... in the federal economic stimulus bill by protecting Medicare ... fiscal 2010 budget proposal. The caregiver coalition warned ...
... risk goes up as age goes down , , WEDNESDAY, Feb. ... at a Detroit emergency room was discharged after health-care professionals ... sharp pain in her left eye and loss of feeling ... she had a migraine. , And a 29-year-old man with ...
... with Medicare coverage is increasing, but a persistent gap ... and all other racial and ethnic groups, according ... and the University of Washington. The study also showed ... , Because Medicare covers all available colorectal cancer screening ...
... A new study involving iPods and teenagers by the University ... who receive pressure from their peers or others to turn ... higher. , The study also showed that teen boys listen ... concern about the risk for and severity of hearing loss ...
... clot-busting drug, study shows , , WEDNESDAY, Feb. 18 (HealthDay News) ... an hour after having the first symptoms of a stroke ... that is the first line of treatment, a new study ... stroke at American hospitals, 27.1 percent of those whose treatment ...
... Congress Urged to Grant FDA Authority over Tobacco ProductsWASHINGTON, Feb. ... aggressive marketing campaigns aimed at women and girls in ... a coalition of public health organizations. The report ... of women and girls at risk and urges Congress to ...
Cached Medicine News:Health News:Coalition to Protect Senior Care Urges Obama Administration to Support Frontline Caregivers by Protecting Medicare Funding in FY 2010 Budget Blueprint 2Health News:ER Less Likely to Diagnose Stroke in Younger Folks 2Health News:ER Less Likely to Diagnose Stroke in Younger Folks 3Health News:Gaps in colorectal cancer screening persist between whites and non-whites 2Health News:New iPod listening study shows surprising behavior of teens 2Health News:New iPod listening study shows surprising behavior of teens 3Health News:Fast Arrival at Hospital After Stroke Pays Off 2Health News:Fast Arrival at Hospital After Stroke Pays Off 3Health News:Deadly in Pink: New Report Warns Big Tobacco Has Stepped Up Targeting of Women and Girls 2Health News:Deadly in Pink: New Report Warns Big Tobacco Has Stepped Up Targeting of Women and Girls 3Health News:Deadly in Pink: New Report Warns Big Tobacco Has Stepped Up Targeting of Women and Girls 4Health News:Deadly in Pink: New Report Warns Big Tobacco Has Stepped Up Targeting of Women and Girls 5
... utilized when a surgeon would like to impact ... seat the anchor below the 10-12 placement of ... the same as what comes with the Collared ... shaft to easier gauge anchor depth during insertion. ...
... USS Sports Medicine™ Ogden™ Non-Sterile Anchor is ... tissue to bone using sutures. The device ... the bone and is used to reattach ... from Titanium (6A14V ELI) alloy which conforms ...
Series I Small Joint Arthroscopy Hand Instruments feature small yet durable instruments specifically designed for small joint arthroscopy. They are available in a variety of low profile styles: strai...
Series I Small Joint Arthroscopy Hand Instruments feature small yet durable instruments specifically designed for small joint arthroscopy. They are available in a variety of low profile styles: strai...
Medicine Products: